Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

    Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

    FromCell & Gene: The Podcast

    Start listeningView podcast show

    Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

    FromCell & Gene: The Podcast

    ratings:
    Length:
    20 minutes
    Released:
    Mar 28, 2024
    Format:
    Podcast episode

    Description

    Orca Bio's CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. They cover Orca Bio's plan to potentially lowering the risk of GvHD as well as Orca-T, the investigational high-precision allogeneic cell therapy being evaluated in clinical trials for the treatment of multiple hematologic malignancies.
    Released:
    Mar 28, 2024
    Format:
    Podcast episode

    Titles in the series (76)

    Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.